IP Library Granted Patent US 10,093,641
Granted Patent B2
US 10,093,641 · App. 15/707,041 · Granted Oct 9, 2018

Process for making beraprost

Inventors: Hitesh Batra (Herndon, VA); Liang Guo (Vienna, VA)
Assignee: United Therapeutics Corporation
C07D307/93
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,093,641
App. No.
15/707,041
Granted
Oct 9, 2018
Kind
B2
Abstract

A method is described for making single isomers of synthetic beraprost diol, a key intermediate for making 314-d isomer of beraprost. The method requires fewer steps than the known methods for making these compounds and can be used to scale up the reaction more easily to produce commercial quantities.

Claims (35)

1. A process comprising:

cyclizing a compound of formula (IV):

to form a compound of formula (V):

wherein R 1a is a cation, H, or C 1-12 alkyl; R 2a is H or an hydroxy protective group; X is a halogen selected from chloro, bromo and iodo.

2. The process of claim 1 , wherein R 2a is acetate, trimethylsilyl, triethylsilyl, t-butyldimethylsilyl, t-butyldiphenylsilyl, phenyldimethylsilyl, tetrahydropyranyl, benzoate ester, benzyl, or substituted benzyl.

3. The process of claim 1 , wherein R 1a is CH 3 and R 2a and R 6 are both H.

4. The process of claim 1 , wherein said cyclizing comprises using azobisisobutyronitrile as a radical initiator.

5. The process of claim 1 , further comprising performing a Mitsunobu reaction on the compound of the following formula:

with a compound of the following formula:

to form the compound of formula (IV).

6. The process of claim 1 , further comprising isomerizing the allyl of the compound of formula (V) to form a propenyl resulting in a compound of formula (VI):

followed by ozonolysis and in situ reduction to convert the propenyl of the compound of formula (VI) to form an alcohol resulting in a compound of formula (VII):

wherein R 6 is H or a hydroxyl protecting group; and

deprotecting the acetate of the compound of formula (VII) to form a compound of formula (VIII):

7. The process of claim 6 , wherein said isomerizing comprises using a catalytic amount of carbonylchlorohydridotris(triphenylphosphine) ruthenium (II).

8. The process of claim 6 , wherein said ozonolysis and in situ reduction produces an in situ trapped aldehyde intermediate represented by the compound of formula (XI)

9. The process of claim 6 , wherein sulfuric acid is used in said deprotecting step.

10. The process of claim 6 , wherein the compound of formula (VIII) is produced as a substantially pure single isomer.

11. The process of claim 6 , further comprising:

selectively deprotecting the primary hydroxy protective group of the compound of formula (VIII), followed by oxidation of the primary hydroxy group to form an aldehyde, followed by coupling with a side-chain of formula (XIII):

wherein R 4 represents H or C 1-3 alkyl and R 5 represents H or C 1-6 alkyl to form a compound of formula (XIV):

reduction of the ketone, deprotection of any remaining hydroxy protective group and optionally converting the R 1a into a cation or H to form a compound of formula (XII):

wherein R 1 represents a cation, H, or C 1-12 alkyl; R 2 and R 3 each represent H or a hydroxy protective group.

12. The process of claim 11 , wherein the compound of formula (XII) is produced as a substantially pure single isomer.

13. The process of claim 6 , further comprising selectively deprotecting the primary hydroxy protective group of the compound of formula (VIII), followed by oxidation of the primary hydroxy group to form an aldehyde, followed by coupling with a side-chain of formula (IX):

wherein R 4 represents H or C 1-3 alkyl and R 5 represents H or C 1-6 alkyl to form a compound

of formula (X):

followed by reduction of the ketone, deprotection of any remaining hydroxy protective group and optionally converting the R 1a into a cation or H to form a compound of formula (I):

wherein R 1 represents a cation, H, or C 1-12 alkyl; R 2 and R 3 each represent H or a hydroxy protective group.

14. The process of claim 13 , wherein the compound of formula (I) is produced as a substantially pure single isomer.

15. The process of claim 6 , further comprising: selectively deprotecting the primary hydroxy protective group of the compound of formula (VIII), followed by oxidation of the primary hydroxy group to form an aldehyde, followed by coupling with a side-chain of the formula:

wherein R 4 represents H or C 1-3 alkyl and R 5 represents H or C 1-6 alkyl above to form a compound of the following formula:

followed by reduction of the ketone, deprotection of any remaining hydroxy protective group and optionally converting the R 1a into a cation or H to form a compound of the following formula:

wherein R 1 represents a cation, H, or C 1-12 alkyl; R 2 and R 3 each represent H or a hydroxy protective group.

16. The process of claim 15 , wherein the compound of formula (XV) is produced as a substantially pure single isomer of the formula

Continuity (3)
Continuation 15234580 · Aug 11, 2016
Provisional Application 62204145 · Aug 12, 2015
Related Publication 20180037563A1 · Feb 8, 2018